Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
This trial is active, not recruiting.
|Conditions||chronic myeloproliferative disorders, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes, myelodysplastic-myeloproliferative diseases, psychosocial effects of cancer and its treatment|
|Treatment||psychosocial assessment and care|
|Sponsor||The Cleveland Clinic|
|Collaborator||National Cancer Institute (NCI)|
|Start date||February 2006|
|End date||December 2008|
|Trial size||36 participants|
|Trial identifier||NCT00281814, CASE-CCF-1035, CASE-CCF-6950, P30CA043703|
RATIONALE: Questionnaires that measure coping may improve the ability to plan supportive care for patients undergoing donor bone marrow transplant.
PURPOSE: This clinical trial is studying coping in patients who are undergoing a donor bone marrow transplant.
Compare modes of illness adjustment, presence or absence of an inpatient lay care-partner, and survival rates
time frame: Through 100 days post transplant
Male or female participants at least 18 years old.
DISEASE CHARACTERISTICS: - Medically suitable for allogeneic bone marrow transplantation PATIENT CHARACTERISTICS: - Resides locally in the Cleveland, Ohio area PRIOR CONCURRENT THERAPY: - Not specified
|Official title||Adjustment to Illness by Survival Rates in Allogeneic Bone Marrow Transplant (BMT): The Relative Importance of Lay Care-Partner Support|
|Description||OBJECTIVES: - Investigate the relative importance of having a consistent inpatient lay care-partner for patients undergoing allogeneic bone marrow transplantation, in terms of the effects on modes of adjustment to illness and survival. OUTLINE: Patients undergo a 40-minute recorded oral interview in person to provide personal and social demographic data using a 20-item questionnaire (The Adjustment to Illness Questionnaire-Bone Marrow Transplantation) at baseline (pre-transplant) and at day 100 post-transplant. PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.|
Call for more information